CClinicalTrials.gg
Status unknownNCT04605328isthmoceleUpdated Nov 3, 2020

Cesarean Scar Defect (CSD); Prevalence, Risk Factors And Possible Associated Symptoms

An observational study in Cesarean Section Complications, sponsored by Assiut University. Status unknown. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-03.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Oct 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
225
Sex
Female
01

Study summary

The study aims to detect the incidence of Cesarean Scar Defect (CSD) in women undergoing CS in Women Health Hospital (WHH), assiut University, to identify risk factors for development of CSD and identify the possible gynaecological symptoms related to CSD.

Read the detailed description

All eligible women, who will undergo CS in Women Health Hospital (WHH) will be seen on regular visits to detect the presence of CSD by ultrasound and identify its characters and a questionnaire will be fulfilled by the candidates about the gynecological symptoms related to CSD and appeared after CS.

02

Conditions studied

  • Cesarean Section Complications

Keywords

  • niche
03

In context

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients admitted to Women Health Hospital for performing CS will be seen on regular visits for ultrasound scan for detection of CSD

Inclusion criteria

  • All women who will undergo transverse lower segment cesarean section after 28 weeks gestational age (electively and Emergency), after counseling and written consent

Exclusion criteria

Exclusion Criteria:

  1. Rupture uterus (unscarred or scarred).
  2. Upper segment CS.
  3. Vertical lower segment CS.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
225 participants (estimated)
Patient registry
No

Interventions

  • OtherTwo dimension and three dimension ultrasound

    Patient will undergo 2D and 3D ultrasound evaluation after CS for detection of CSD

06

What researchers measure

Primary outcomes

  1. the incidence of CSD in Women health Hospital

    the incidence of CSD in Women health Hospital

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04605328
Lead sponsor
Assiut University
Responsible party
Mohamed Bahaa (Principle Investigator, Assiut University) — Principal investigator
First posted
Oct 28, 2020
Start date
Dec 1, 2020 (estimated)
Primary completion
Dec 1, 2021 (estimated)
Completion
Dec 30, 2021 (estimated)
Last update
Nov 3, 2020

Study contacts

Mohamed Bahaa El-Dine, Master
Contact
midobahaa39@yahoo.com
++201022422960
Ayman shamaash, PHD
study director · Assiut University
Sherif Badran, MD
study chair · Assiut University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion